Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (351-360 of 606) with videos related to

Pageof 61
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Synapse (New York, N.Y.)|April 15, 2000
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implicationsM H Baumann, M A Ayestas, C M Dersch, et al.
Synapse (New York, N.Y.)|April 20, 2001
Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptorH Xu, Y F Lu, J B Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
Neuropharmacology|September 1, 1990
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptorsR B Rothman, J B Long, V Bykov, et al.
Journal of Molecular Biology|April 1, 2008
Insight into DNA and protein transport in double-stranded DNA viruses: the structure of bacteriophage N4Kyung H Choi, Jennifer McPartland, Irene Kaganman, et al.
The Journal of Clinical Investigation|August 30, 2005
Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of LangerhansAlexander S Banks, Jianze Li, Lisa McKeag, et al.
NIDA Research Monograph|January 1, 1991
Pseudoirreversible binding of opiates to opioid receptor subtypes in rat brain: a quantitative studyH Xu, C H Kim, Y C Zhu, et al.
Pageof 61

Showing results (351-360 of 606) with videos related to

Sort By:
Pageof 61
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Synapse (New York, N.Y.)|April 15, 2000
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implicationsM H Baumann, M A Ayestas, C M Dersch, et al.
Synapse (New York, N.Y.)|April 20, 2001
Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptorH Xu, Y F Lu, J B Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
Neuropharmacology|September 1, 1990
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptorsR B Rothman, J B Long, V Bykov, et al.
Journal of Molecular Biology|April 1, 2008
Insight into DNA and protein transport in double-stranded DNA viruses: the structure of bacteriophage N4Kyung H Choi, Jennifer McPartland, Irene Kaganman, et al.
The Journal of Clinical Investigation|August 30, 2005
Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of LangerhansAlexander S Banks, Jianze Li, Lisa McKeag, et al.
NIDA Research Monograph|January 1, 1991
Pseudoirreversible binding of opiates to opioid receptor subtypes in rat brain: a quantitative studyH Xu, C H Kim, Y C Zhu, et al.
Pageof 61